INBP insider transaction filings
INTEGRATED BIOPHARMA INC — 24 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-25. Screen INBP transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-25 | 4 | Milmoe William H. — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Canarick Robert — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | DeSantis Damon — Director, 10% owner | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Friedman Eric J — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4/A | Friedman Eric J — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | Milmoe William H. — Director | Gift (G): 8,966,547 @ $0 · Gift (G): 2,235,417 @ $0 | EDGAR |
| 2026-04-17 | 4 | DeSantis Damon — Director, 10% owner | Gift (G): 8,966,547 @ $0 · Gift (G): 2,235,417 @ $0 | EDGAR |
| 2026-04-17 | 4 | DESANTIS CARL — 10% owner | Gift (G): 8,966,547 @ $0 · Gift (G): 2,235,417 @ $0 | EDGAR |
| 2026-04-17 | 4/A | Milmoe William H. — Director | Gift (G): 8,966,547 @ $0 · Gift (G): 2,235,417 @ $0 | EDGAR |
| 2026-03-26 | 4 | DESANTIS CARL — 10% owner | Gift (G): 1,356,293 @ $0 · Gift (G): 7,392 @ $0 | EDGAR |
| 2026-03-25 | 4 | Milmoe William H. — Director, 10% owner | Gift (G): 1,356,293 @ $0 · Gift (G): 7,392 @ $0 | EDGAR |
| 2026-03-25 | 4 | DeSantis Damon — Director | Gift (G): 1,356,293 @ $0 · Gift (G): 7,392 @ $0 | EDGAR |
| 2025-12-10 | 4 | Masi Dina — Chief Financial Officer | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | KAY CHRISTINA — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | RIVA SHEPPARD — Co-Chief Executive Officer, 10% owner | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | DeSantis Damon — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Milmoe William H. — Director, 10% owner | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | FRIEDMAN ERIC J — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Canarick Robert — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Milmoe William H. — Director, 10% owner | Grant/award (A): 50,000 @ $0.09 · Disposition to issuer (D): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | RIVA SHEPPARD — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 144,445 @ $0.09 · Disposition to issuer (D): 144,445 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | KAY CHRISTINA — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 144,445 @ $0.09 · Disposition to issuer (D): 144,445 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Masi Dina — Chief Financial Officer | Grant/award (A): 135,000 @ $0.09 · Disposition to issuer (D): 135,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Canarick Robert — Director | Grant/award (A): 175,000 @ $0.09 · Disposition to issuer (D): 175,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — INTEGRATED BIOPHARMA INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-20 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-01 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=INBP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →